Hans Hammers, MD, PhD – Driving Immunotherapy Combinations Into the Modern Age of Kidney Cancer Care

Dr. Hans Hammers is a distinguished professor in the Department of Internal Medicine at UT Southwestern Medical Center. He is also a co-leader for clinical research and immunotherapy in the Kidney Cancer Research Program, as well as the Experimental Therapeutics Program.

In this exclusive interview, Dr. Hammers provides insight into his journey as a leading expert in kidney cancer research and immunotherapy. He discusses the pivotal clinical trials he has led that have significantly impacted outcomes for patients with kidney cancer and shares his perspectives on the future of novel immunotherapies and targeted therapies.


Latest News

Editorial Advisory Board

Expert Interviews

Knowledge Hubs

Curated clinical content based on conditions, therapies, and technologies

Prostate Cancer
Prostate Cancer

The Uromigos

Podcasts hosted by Professors Thomas Powles, MD, and Brian Rini, MD

Conference Coverage

Live meeting highlights

Petros Grivas, MD, PhDUromigos Live 2023 | September 21, 2023
Dr. Petros Grivas shares what data he's most looking forward to discussing at the second Uromigos: Live & Unplugged event.
View More
Emily MenendezUromigos Live 2023 | August 29, 2023
The second annual Uromigos: Live & Unplugged event will take place in Nashville, Tennessee, on November 3-4.
Ajitha Kommalapati, MDASCO 2023 | August 15, 2023
Dr. Kommalapati shares her thoughts on the association between tumor-informed MRD and clinical outcomes for MIBC.
Shilpa Gupta, MDASCO 2023 | August 4, 2023
Drs. Shilpa Gupta and Vadim Koshkin continue on the EV-103 trial with reference to outcomes and toxicities in cohort K.

Video Insights

Clinical discussions with experts in the field

Network Websites